                               SEQUENCE LISTING

<110> ILLUMINA, INC.
 
<120> COMPOSITIONS AND METHODS FOR SEQUENCING USING AT LEAST
      ELECTRICAL CHARACTERISTICS

<130> IP-1969-PCT

<140>
<141>

<150> 63/046,618
<151> 2020-06-30

<160> 11    

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Gly Phe Pro Arg Phe Ala Gly Phe Pro 
1               5                   


<210> 2
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Phe Lys Glu Phe Ala Lys Leu Phe Lys Glu Phe Ala Lys Leu Phe His 
1               5                   10                  15      


Lys Phe Ala Lys Leu 
            20      


<210> 3
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Leu Lys Glu Leu Ala Lys Leu Leu Lys Glu Leu Ala Lys Leu Leu His 
1               5                   10                  15      


Glu Leu Ala Lys Leu 
            20      


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Lys Gly Lys Gly Lys Gly Lys 
1               5           


<210> 5
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Leu Arg Ala Leu Leu Arg Ala Leu Leu Arg Ala Leu 
1               5                   10          


<210> 6
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Lys Leu Lys Leu Lys Leu Lys Leu Lys Leu Lys Leu Lys Leu 
1               5                   10                  


<210> 7
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Leu Arg Leu Arg Leu Arg Leu Arg Leu Arg Leu Phe Pro Val Arg Leu 
1               5                   10                  15      


Arg Leu Arg Leu Arg Leu Arg Leu 
            20                  


<210> 8
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 8
gctaaaaaga gagagagatc g                                                 21


<210> 9
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 9
cgatctctct ctctttttag c                                                 21


<210> 10
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Glu Leu Lys Ala Ile Ala Gln Glu Phe Lys Ala Ile Ala Lys Glu Phe 
1               5                   10                  15      


Lys Ala Ile Ala Phe Glu Phe Lys Ala Ile Ala Gln Lys 
            20                  25                  


<210> 11
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 11
gggaaaggaa acttaaaaaa aaggg                                             25


